Survival rates for 1493 individuals with thalassemia who underwent hematopoietic cell transplantation between the years 2000 to 2010
This figure shows outcomes for the entire population (all ages [mostly children], all donors, all sources of hematopoietic stem cells). Overall survival is shown in (A) and thalassemia-free survival is shown in (B). The probabilities in the table are for overall survival and thalassemia-free survival at two years. Refer to UpToDate for additional discussion of the factors that affect outcomes and our approach to thalassemia management.
Reprinted by permission of Macmillan Publishers Ltd: Bone Marrow Transplantation. Baronciani D, Angelucci E, Potschger U, et al. Hematopoietic stem cell transplantation in thalassemia: A report from the European Society for Blood and Bone Marrow Transplantation Hemoglobinopathy Registry, 2000-2010. Bone Marrow Transplant 2016; 51:536. Copyright © 2016.
www.nature.com/bmt.